Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China ...

Herbert, 67, passed away peacefully surrounded by family on Wednesday, January 8, 2025, at Cheshire Medical Center in Keene ...

The decision to expand the trial was made following the completion of monotherapy dose escalation for SON-1010.

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters combination evaluation with trabectedin (Yondelis®) with ...

A breakthrough in Russia promises to redefine cancer treatment, with the country announcing its first mRNA cancer vaccine.

https://doi.org/10.1002/1097-0142(19820301)49:5<878::aid-cncr2820490510>3.0.co;2-r has been cited by the following article: TITLE: Radiation-Induced Liposarcoma of ...

The reason it took so long, he said, was because there is only one doctor in Seattle who specializes in sarcoma, a rare type of cancer that develops in the body’s connective tissues, such as bones, ...

NEW YORK – When the US Food and Drug Administration approved Tecelra (afamitresgene autoleucel) in August 2024 for certain patients with advanced sarcoma, Adaptimmune became the second company to ever ...

ABSTRACT: Background: The low-grade fibromyxoid sarcoma (LGFMS) is an exceptionally uncommon sarcoma that primarily manifests in the extremities or trunk of young adults, presenting as painless ...

compared to placebo in patients with stage III undifferentiated pleomorphic sarcoma or dedifferentiated liposarcoma of the extremity. 1 Topline data revealed an estimated 2-year survival benefit in ...